PGEN
Precigen Inc
Price:  
1.62 
USD
Volume:  
611,400.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PGEN EV/EBITDA

-425.1%
Upside

As of 2025-07-05, the EV/EBITDA ratio of Precigen Inc (PGEN) is -4.06. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PGEN's latest enterprise value is 472.13 mil USD. PGEN's TTM EBITDA according to its financial statements is -116.25 mil USD. Dividing these 2 quantities gives us the above PGEN EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 11.9x - 13.8x 13.2x
Forward P/E multiples 12.2x - 16.1x 13.6x
Fair Price (4.79) - (5.41) (5.27)
Upside -395.8% - -433.7% -425.1%
1.62 USD
Stock Price
(5.27) USD
Fair Price

PGEN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-07-03 -4.06
2025-07-02 -4.04
2025-07-01 -3.63
2025-06-30 -3.55
2025-06-27 -3.55
2025-06-26 -3.58
2025-06-25 -3.55
2025-06-24 -3.76
2025-06-23 -3.71
2025-06-20 -3.63
2025-06-18 -3.73
2025-06-17 -3.55
2025-06-16 -3.86
2025-06-13 -3.81
2025-06-12 -3.81
2025-06-11 -3.76
2025-06-10 -3.86
2025-06-09 -3.76
2025-06-06 -3.76
2025-06-05 -3.32
2025-06-04 -3.32
2025-06-03 -3.40
2025-06-02 -3.32
2025-05-30 -3.30
2025-05-29 -3.48
2025-05-28 -3.43
2025-05-27 -3.53
2025-05-23 -3.43
2025-05-22 -3.48
2025-05-21 -3.30
2025-05-20 -3.53
2025-05-19 -3.40
2025-05-16 -3.63
2025-05-15 -3.27
2025-05-14 -3.20
2025-05-13 -3.38
2025-05-12 -3.43
2025-05-09 -3.32
2025-05-08 -3.38
2025-05-07 -3.38
2025-05-06 -3.49
2025-05-05 -3.81
2025-05-02 -3.93
2025-05-01 -3.88
2025-04-30 -3.91
2025-04-29 -3.86
2025-04-28 -3.88
2025-04-25 -3.76
2025-04-24 -3.99
2025-04-23 -4.06